Tubacex Statistics
Total Valuation
Tubacex has a market cap or net worth of EUR 354.57 million. The enterprise value is 867.67 million.
| Market Cap | 354.57M |
| Enterprise Value | 867.67M |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Jun 12, 2026 |
Share Statistics
Tubacex has 122.27 million shares outstanding.
| Current Share Class | 122.27M |
| Shares Outstanding | 122.27M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 32.18% |
| Float | 99.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 15.57 |
| PS Ratio | 0.53 |
| PB Ratio | 1.24 |
| P/TBV Ratio | 2.03 |
| P/FCF Ratio | 16.84 |
| P/OCF Ratio | 5.51 |
| PEG Ratio | 0.34 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.62, with an EV/FCF ratio of 41.17.
| EV / Earnings | n/a |
| EV / Sales | 1.30 |
| EV / EBITDA | 33.62 |
| EV / EBIT | n/a |
| EV / FCF | 41.17 |
Financial Position
The company has a current ratio of 1.18, with a Debt / Equity ratio of 1.28.
| Current Ratio | 1.18 |
| Quick Ratio | 0.47 |
| Debt / Equity | 1.28 |
| Debt / EBITDA | 19.69 |
| Debt / FCF | 24.01 |
| Interest Coverage | -0.93 |
Financial Efficiency
Return on equity (ROE) is -11.99% and return on invested capital (ROIC) is -2.98%.
| Return on Equity (ROE) | -11.99% |
| Return on Assets (ROA) | -1.18% |
| Return on Invested Capital (ROIC) | -2.98% |
| Return on Capital Employed (ROCE) | -3.69% |
| Weighted Average Cost of Capital (WACC) | 5.15% |
| Revenue Per Employee | 255,425 |
| Profits Per Employee | -20,419 |
| Employee Count | 2,755 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 0.76 |
Taxes
| Income Tax | -1.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.96% in the last 52 weeks. The beta is 0.48, so Tubacex's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -14.96% |
| 50-Day Moving Average | 2.76 |
| 200-Day Moving Average | 3.02 |
| Relative Strength Index (RSI) | 57.94 |
| Average Volume (20 Days) | 224,215 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Tubacex had revenue of EUR 668.96 million and -53.48 million in losses. Loss per share was -0.44.
| Revenue | 668.96M |
| Gross Profit | 349.46M |
| Operating Income | -23.66M |
| Pretax Income | -52.26M |
| Net Income | -53.48M |
| EBITDA | 23.97M |
| EBIT | -23.66M |
| Loss Per Share | -0.44 |
Balance Sheet
The company has 101.40 million in cash and 506.40 million in debt, with a net cash position of -405.00 million or -3.31 per share.
| Cash & Cash Equivalents | 101.40M |
| Total Debt | 506.40M |
| Net Cash | -405.00M |
| Net Cash Per Share | -3.31 |
| Equity (Book Value) | 395.20M |
| Book Value Per Share | 2.35 |
| Working Capital | 98.10M |
Cash Flow
In the last 12 months, operating cash flow was 64.42 million and capital expenditures -43.33 million, giving a free cash flow of 21.09 million.
| Operating Cash Flow | 64.42M |
| Capital Expenditures | -43.33M |
| Depreciation & Amortization | 47.62M |
| Net Borrowing | -18.15M |
| Free Cash Flow | 21.09M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 52.24%, with operating and profit margins of -3.54% and -7.99%.
| Gross Margin | 52.24% |
| Operating Margin | -3.54% |
| Pretax Margin | -7.81% |
| Profit Margin | -7.99% |
| EBITDA Margin | 3.58% |
| EBIT Margin | -3.54% |
| FCF Margin | 3.09% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 7.02%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 7.02% |
| Dividend Growth (YoY) | -75.44% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| FCF Payout Ratio | 28.99% |
| Buyback Yield | n/a |
| Shareholder Yield | 7.01% |
| Earnings Yield | -15.08% |
| FCF Yield | 5.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Analyst Forecast
The average price target for Tubacex is 4.05, which is 39.66% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 4.05 |
| Price Target Difference | 39.66% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 7.79% |
| EPS Growth Forecast (3Y) | 38.26% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |